Lotemax
Payments companies reported to CMS as associated with Lotemax. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lotemax, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lotemax
These are the largest totals companies reported as associated with Lotemax. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Neil Bressler | Baltimore, MD | Ophthalmology | $4,000.00 |
| Mark Barakat | Scottsdale, AZ | Ophthalmology | $4,000.00 |
| Mathew Maccumber | Harvey, IL | Retina Specialist | $3,500.00 |
| Mitchell Weikert | Houston, TX | Ophthalmology | $2,500.00 |
| Ming Chen | Honolulu, HI | Ophthalmology | $2,060.00 |
| Bryan Kimura | Arcadia, CA | Optometrist | $2,000.00 |
| Deborah Duan | Pasadena, CA | Optometrist | $2,000.00 |
| Christina Liu | South Pasadena, CA | Optometrist | $2,000.00 |
| Andrew Iwach | San Francisco, CA | Ophthalmology | $2,000.00 |
| Ramon Lee | Royal Oak, MI | Retina Specialist | $2,000.00 |
Prescribed Lotemax?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.